While researchers see 3D printed organs in a clinical setting to be something like twenty years out most regular consumers see it a something that is bound to happen in a few years. In the middle of this exciting development sits the Advanced Solutions LifeSciences which makes bioprinters, bioprinting software and bioinks and is a part of the larger firm, Kentucky based Advanced Solutions Inc.(ASI). We interviewed Michael Golway the CEO of ASI and the company’s scientific advisor James Hoying to find out what they’re doing in bioprinting.
Read complete story here.
Share this Post